These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 35412385)

  • 1. Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era.
    Reedman CN; Drews SJ; Yi QL; Pambrun C; O'Brien SF
    Microbiol Spectr; 2022 Apr; 10(2):e0033922. PubMed ID: 35412385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of SARS-CoV-2 seroprevalence estimates between commercial lab serum specimens and blood donor specimens, United States, September-December 2021.
    Kao S-YZ; Nycz E; Benoit TJ; Clarke KEN; Jones JM
    Microbiol Spectr; 2024 Aug; 12(8):e0012324. PubMed ID: 38869287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health.
    O'Brien SF; Caffrey N; Yi QL; Bolotin S; Janjua NZ; Binka M; Thanh CQ; Stein DR; Lang A; Colquhoun A; Pambrun C; Reedman CN; Drews SJ
    Microbiol Spectr; 2023 Feb; 11(1):e0335622. PubMed ID: 36625634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History.
    Drews SJ; Hu Q; Samson R; Abe KT; Rathod B; Colwill K; Gingras AC; Yi QL; O'Brien SF
    Microbiol Spectr; 2022 Feb; 10(1):e0226221. PubMed ID: 35171006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
    JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays.
    Tuite AR; Fisman D; Abe KT; Rathod B; Pasculescu A; Colwill K; Gingras AC; Yi QL; O'Brien SF; Drews SJ
    Microbiol Spectr; 2022 Feb; 10(1):e0256321. PubMed ID: 35196819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study.
    Lewin A; De Serres G; Grégoire Y; Perreault J; Drouin M; Fournier MJ; Tremblay T; Beaudoin J; Boivin A; Goyette G; Finzi A; Bazin R; Germain M; Delage G; Renaud C
    Can J Public Health; 2022 Jun; 113(3):385-393. PubMed ID: 35380364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021.
    Busch MP; Stramer SL; Stone M; Yu EA; Grebe E; Notari E; Saa P; Ferg R; Manrique IM; Weil N; Fink RV; Levy ME; Green V; Cyrus S; Williamson PC; Haynes J; Groves J; Krysztof D; Custer B; Kleinman S; Biggerstaff BJ; Opsomer JD; Jones JM
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S254-S263. PubMed ID: 35684973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada.
    Skowronski DM; Kaweski SE; Irvine MA; Kim S; Chuang ESY; Sabaiduc S; Fraser M; Reyes RC; Henry B; Levett PN; Petric M; Krajden M; Sekirov I
    CMAJ; 2022 Dec; 194(47):E1599-E1609. PubMed ID: 36507788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riding high: seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020-February 2022.
    Duong S; Burtniak J; Gretchen A; Mai A; Klassen P; Wei Y; Loeppky C; Shaw SY; Bullard J; Van Caeseele P; Stein DR
    BMC Public Health; 2023 Dec; 23(1):2420. PubMed ID: 38053033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serosurveillance of SARS-CoV-2 in Welsh Blood Donors: Establishment of the surveillance system and results up to November 2022.
    Harker S; James SE; Murphy J; Davies B; Moore C; Tennant BP; Geen J; Thomas D
    Euro Surveill; 2023 May; 28(19):. PubMed ID: 37166761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron.
    O'Brien SF; Caffrey N; Yi QL; Pambrun C; Drews SJ
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard.
    Saeed S; O'Brien SF; Abe K; Yi QL; Rathod B; Wang J; Fazel-Zarandi M; Tuite A; Fisman D; Wood H; Colwill K; Gingras AC; Drews SJ
    PLoS One; 2021; 16(9):e0257743. PubMed ID: 34555095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.
    Stone M; Di Germanio C; Wright DJ; Sulaeman H; Dave H; Fink RV; Notari EP; Green V; Strauss D; Kessler D; Destree M; Saa P; Williamson PC; Simmons G; Stramer SL; Opsomer J; Jones JM; Kleinman S; Busch MP;
    Clin Infect Dis; 2022 Mar; 74(5):871-881. PubMed ID: 34111244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021.
    Stringhini S; Zaballa ME; Pullen N; Perez-Saez J; de Mestral C; Loizeau AJ; Lamour J; Pennacchio F; Wisniak A; Dumont R; Baysson H; Richard V; Lorthe E; Semaani C; Balavoine JF; Pittet D; Vuilleumier N; Chappuis F; Kherad O; Azman AS; Posfay-Barbe K; Kaiser L; Guessous I;
    Euro Surveill; 2021 Oct; 26(43):. PubMed ID: 34713799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 seroprevalence in Nova Scotia blood donors.
    O'Brien SF; Deeks SL; Hatchette T; Pambrun C; Drews SJ
    J Assoc Med Microbiol Infect Dis Can; 2024 Mar; 9(1):32-45. PubMed ID: 38567363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023.
    Murphy TJ; Swail H; Jain J; Anderson M; Awadalla P; Behl L; Brown PE; Charlton CL; Colwill K; Drews SJ; Gingras AC; Hinshaw D; Jha P; Kanji JN; Kirsh VA; Lang ALS; Langlois MA; Lee S; Lewin A; O'Brien SF; Pambrun C; Skead K; Stephens DA; Stein DR; Tipples G; Van Caeseele PG; Evans TG; Oxlade O; Mazer BD; Buckeridge DL
    CMAJ; 2023 Aug; 195(31):E1030-E1037. PubMed ID: 37580072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
    Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM
    JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022.
    Bloch EM; Kyeyune D; White JL; Ddungu H; Ashokkumar S; Habtehyimer F; Baker O; Kasirye R; Patel EU; Grabowski MK; Musisi E; Moses K; Hume HA; Lubega I; Shrestha R; Motevalli M; Fernandez RE; Reynolds SJ; Redd AD; Wambongo Musana H; Dhabangi A; Ouma J; Eroju P; de Lange T; Fowler MG; Musoke P; Stramer SL; Whitby D; Zimmerman PA; McCullough J; Sachithanandham J; Pekosz A; Goodrich R; Quinn TC; Ness PM; Laeyendecker O; Tobian AAR
    Transfusion; 2023 Jul; 63(7):1354-1365. PubMed ID: 37255467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.